{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":3,"sponsored":0,"items":[{"id":"n_mm4ydohuwbcrwduqtyta","seq":12505147,"kind":"article","title":"Biocon's Pertuzumab Receives Marketing Authorization in EU, First Biosimilar Authorized Under EMA's New Tailored Clinical Approach","url":"https://www.finanznachrichten.de/nachrichten-2026-11/70166972-biocon-s-pertuzumab-receives-marketing-authorization-in-eu-first-biosimilar-authorized-under-ema-s-new-tailored-clinical-approach-008.htm","published":"2026-11-18T14:24:00Z","seen":"2026-11-18T15:06:42Z","lang":"en","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["PR Newswire"],"entities":[{"id":"Q487694","name":"Biocon","type":"org"},{"id":"Q1998021","name":"pertuzumab","type":"other"},{"id":"Q458","name":"European Union","type":"place"},{"id":"Q130146","name":"European Medicines Agency","type":"org"}],"story":"st_cxeaggv2mk6jarsf5lpq","category":"health","category_p":0.39,"category2":"economy-business","sentiment":"positive","tone":0.21,"political":0.08},{"id":"n_unicwofbrv2sgeevgdbq","seq":12323980,"kind":"article","title":"Biocon gets US FDA approval for Pebrilzo™ Injection, biosimilar to Perjeta®, expanding oncology portfolio","url":"https://www.biospectrumindia.com/news/104/28835/biocon-gets-us-fda-approval-for-pebrilzo-injection-biosimilar-to-perjeta-expanding-oncology-portfolio.html","published":"2026-11-18T05:07:00Z","seen":"2026-11-18T05:07:00Z","lang":"en","source":{"id":"biospectrumindia.com","name":"biospectrumindia.com","domain":"biospectrumindia.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"entities":[{"id":"Q487694","name":"Biocon","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q29006332","name":"Perjeta","type":"other"}],"story":"st_e63lcdrduw7atxdmztxa","category":"health","category_p":0.38,"category2":"economy-business","sentiment":"positive","tone":0.44,"political":0.17},{"id":"n_avurs67sh272zlq54jsq","seq":4663447,"kind":"article","title":"Biocon's Pertuzumab Biosimilar Receives Positive CHMP Opinion Under EMA's Tailored Clinical Approach - Healthcare","url":"https://www.mondaq.com/unitedstates/healthcare/1859342/biocons-pertuzumab-biosimilar-receives-positive-chmp-opinion-under-emas-tailored-clinical-approach","published":"2026-10-26T02:08:29Z","seen":"2026-10-26T02:08:29Z","lang":"en","country":"US","source":{"id":"mondaq.com","name":"mondaq.com","domain":"mondaq.com","outlet":{"wikidata":"Q96393761","name":"Mondaq","type":"website","country":"US","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","politics","health","business"],"entities":[{"id":"Q487694","name":"Biocon","type":"org"},{"id":"Q1998021","name":"pertuzumab","type":"other"}],"story":"st_avurs67sh272zlq54jsq","category":"health","category_p":0.68,"sentiment":"positive","tone":0.53,"political":0.05}]}